These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9895299

  • 1. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity.
    Okamoto O, Fujiwara S, Abe M, Sato Y.
    Biochem J; 1999 Feb 01; 337 ( Pt 3)(Pt 3):537-41. PubMed ID: 9895299
    [Abstract] [Full Text] [Related]

  • 2. The bioactivity of transforming growth factor-beta1 can be regulated via binding to dermal collagens in mink lung epithelial cells.
    Shibuya H, Okamoto O, Fujiwara S.
    J Dermatol Sci; 2006 Mar 01; 41(3):187-95. PubMed ID: 16337361
    [Abstract] [Full Text] [Related]

  • 3. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
    Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E.
    Matrix Biol; 2006 Aug 01; 25(6):332-41. PubMed ID: 16766169
    [Abstract] [Full Text] [Related]

  • 4. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen.
    Schönherr E, Broszat M, Brandan E, Bruckner P, Kresse H.
    Arch Biochem Biophys; 1998 Jul 15; 355(2):241-8. PubMed ID: 9675033
    [Abstract] [Full Text] [Related]

  • 5. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells.
    Li X, McFarland DC, Velleman SG.
    Domest Anim Endocrinol; 2008 Oct 15; 35(3):263-73. PubMed ID: 18650056
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta/extracellular matrix interactions in dentin matrix: a role in regulating sequestration and protection of bioactivity.
    Baker SM, Sugars RV, Wendel M, Smith AJ, Waddington RJ, Cooper PR, Sloan AJ.
    Calcif Tissue Int; 2009 Jul 15; 85(1):66-74. PubMed ID: 19424740
    [Abstract] [Full Text] [Related]

  • 7. Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.
    van Waarde MA, van Assen AJ, Kampinga HH, Konings AW, Vujaskovic Z.
    Anal Biochem; 1997 Apr 05; 247(1):45-51. PubMed ID: 9126369
    [Abstract] [Full Text] [Related]

  • 8. Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1.
    Murakami S, Takashima H, Sato-Watanabe M, Chonan S, Yamamoto K, Saitoh M, Saito S, Yoshimura H, Sugawara K, Yang J, Gao N, Zhang X.
    FEBS Lett; 2004 May 21; 566(1-3):55-9. PubMed ID: 15147868
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM, Xie Z, Young MF, Nielsen KL.
    J Cell Biochem; 2004 Oct 15; 93(3):463-75. PubMed ID: 15372625
    [Abstract] [Full Text] [Related]

  • 10. Dermatopontin, a novel player in the biology of the extracellular matrix.
    Okamoto O, Fujiwara S.
    Connect Tissue Res; 2006 Oct 15; 47(4):177-89. PubMed ID: 16987749
    [Abstract] [Full Text] [Related]

  • 11. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S, Dean DD, Gomez R, Schwartz Z, Boyan BD.
    Calcif Tissue Int; 2002 Jan 15; 70(1):54-65. PubMed ID: 11907708
    [Abstract] [Full Text] [Related]

  • 12. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.
    Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB.
    Anal Biochem; 1994 Feb 01; 216(2):276-84. PubMed ID: 8179182
    [Abstract] [Full Text] [Related]

  • 13. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo.
    Ständer M, Naumann U, Dumitrescu L, Heneka M, Löschmann P, Gulbins E, Dichgans J, Weller M.
    Gene Ther; 1998 Sep 01; 5(9):1187-94. PubMed ID: 9930319
    [Abstract] [Full Text] [Related]

  • 14. Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells.
    Solovyan VT, Keski-Oja J.
    J Cell Physiol; 2006 May 01; 207(2):445-53. PubMed ID: 16447253
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt.
    Ju EM, Choi KC, Hong SH, Lee CH, Kim BC, Kim SJ, Kim IH, Park SH.
    Biochem Biophys Res Commun; 2005 Mar 25; 328(4):1170-81. PubMed ID: 15708000
    [Abstract] [Full Text] [Related]

  • 16. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
    Yamamoto T, Eckes B, Krieg T.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):200-5. PubMed ID: 11178980
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
    Zhang Z, Li XJ, Liu Y, Zhang X, Li YY, Xu WS.
    Burns; 2007 Aug 16; 33(5):634-41. PubMed ID: 17374457
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.
    Dong F, Wu HB, Hong J, Rechler MM.
    J Cell Physiol; 2002 Jan 16; 190(1):63-73. PubMed ID: 11807812
    [Abstract] [Full Text] [Related]

  • 19. Decorin binds myostatin and modulates its activity to muscle cells.
    Miura T, Kishioka Y, Wakamatsu J, Hattori A, Hennebry A, Berry CJ, Sharma M, Kambadur R, Nishimura T.
    Biochem Biophys Res Commun; 2006 Feb 10; 340(2):675-80. PubMed ID: 16380093
    [Abstract] [Full Text] [Related]

  • 20. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A, Tredget EE, Mi L, Yang L.
    Exp Cell Res; 1999 Aug 25; 251(1):111-20. PubMed ID: 10438576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.